Project Grant R01MD021852
Award Date 9/1/26
Completion Date 11/30/30
Dollars Obligated $3.1M
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
- The National Institute for Minority Health and Health Disparities awarded The Ohio State University $775,836 on August 5, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to modernize gynecologic cancer clinical trial eligibility criteria and increase enrollment among racial and ethnic minority patients. The project will examine how broadening gynecologic cancer clinical trial exclusion criteria affects the racial and ethnic composition of trial-eligible...
- The National Cancer Institute awarded Oregon Health & Science University a $596,996 cooperative agreement on April 1, 2026, to develop and pilot the Bundled Outreach of Multiple Cancer Screenings for Under-Screened Populations (BUNDLE) intervention under the Cancer Cause and Prevention Research program (CFDA 93.393). BUNDLE adapts previously tested multicomponent outreach interventions to promote guideline-concordant screening for multiple cancers simultaneously—lung, breast, colorectal, and...
- The National Institute for Minority Health and Health Disparities awarded the University of North Carolina at Chapel Hill $495,036 on September 14, 2025, under the Minority Health and Health Disparities Research program (CFDA 93.307) to develop and test a multi-level, community-engaged intervention addressing cervical cancer screening access barriers in rural North Carolina. The funded research develops a Community Advisory Board to inform intervention design, co-develops a protocol with the...
- The National Institute for Minority Health and Health Disparities, part of the Department of Health and Human Services National Institutes of Health, awarded Ochin, Inc. a Project Grant of $1,460,161 on August 15, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307). Ochin will create an integrated dataset by harmonizing data from national, state, and local sources to investigate the longitudinal relationship between housing transitions and health outcomes for...
- The National Institute for Minority Health and Health Disparities awarded George Washington University $2,745,450 on September 19, 2025, under the Minority Health and Health Disparities Research program (CFDA 93.307) to evaluate an SMS text-based patient navigation intervention for colorectal cancer screening among persons experiencing homelessness. The project will deploy mHealth-based navigation through shelter-clinics operated by Project Renewal, a community organization serving the...
- The National Institutes of Health National Human Genome Research Institute awarded the Northwest Portland Area Indian Health Board $500,000 on September 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support the Northwest Native American Research Center for Health (NW NARCH), a tribal-academic partnership designed to develop tribal research capacity and address critical tribal health issues. NW NARCH operates as a collaborative effort between the Northwest...
- The National Institute for Minority Health and Health Disparities awarded Icahn School of Medicine at Mount Sinai $1,329,731 on July 19, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to conduct EXPAND-PC, an intervention linking prostate cancer screening with socioeconomic needs assessments and community support resources for men aged 40–69 residing in New York City Housing Authority developments. The study addresses declining prostate cancer screening...
- The National Cancer Institute awarded Ochin, Inc. $1.267 million on September 23, 2025, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct a longitudinal, multi-level study examining the associations between social risk screening, social risk factors, and cancer healthcare utilization and outcomes among Latino and community health center patients. The study uses electronic health record data from a community health center network operating across more than 40 states,...
- The National Cancer Institute awarded the University of Washington $203,939 on September 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to implement a team-based care model designed to increase cervical cancer screening uptake in low-resource primary care settings. The project, titled "Implementing a Team-Based Care Model to Increase Cervical Cancer Screening Uptake in Low-Resource Primary Care Settings," addresses persistently low screening rates in rural and...
- The National Cancer Institute, part of the Department of Health and Human Services, awarded Oregon Health & Science University $216,822 on September 1, 2026, under the Cancer Biology Research program (CFDA 93.396) to define the PARP14 interactome in RIG-I activated colorectal cancers. The research explores how RIG-I, a cellular RNA sensor, activates immune responses against colorectal cancer when triggered by synthetic viral RNA nucleic acids. Preliminary studies show that PARP14...